33 /100
MEDIUM RISK
Score updated Jul 13, 2026

PRTA — Prothena Corporation plc Dilution Risk Tracker

Track PRTA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PRTA — Get alerts when the score changes →

As of July 13, 2026, Prothena Corporation plc (PRTA) has a DilutionWatch DilutionScore of 33/100, rated MEDIUM dilution risk. Prothena Corporation plc has a market capitalization of $532.96M, 52.35M shares outstanding, 187 institutional holders tracked. Key dilution vectors include approximately 27 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
35
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for PRTA.
🔔 Track PRTA — Get forecast alerts →

💹 Market Data

Market Cap$532.96M
Shares Outstanding52.35M
Float36.75M
Cash$329.46M
Debt$7.65M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 2.6% shares (2026Q1 vs prior)
187 institutional holders · 52.45M shares
#1 FMR LLC 7.55M shares
#2 Rubric Capital Management LP 5.00M shares
#3 BlackRock, Inc. 4.64M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest8.37M
Days to Cover11.0
% of Float22.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for PRTA Shareholders

Prothena Corporation plc (PRTA) has a DilutionScore of 33/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for PRTA shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for PRTA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PRTA alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track PRTA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PRTA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for PRTA
📊 PRTA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PRTA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.